Francesca Schiano Di Cola (Francesca Schiano di Cola)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Cross Sectional

Transcription Factor

Respiratory Syndrome Coronavirus

Top Venues

European journal of neurology

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Schiano Di Cola, Marco Bolchini, Giulia Ceccardi, Salvatore Caratozzolo, Paolo Liberini, Renata Rao, Alessandro Padovani
An observational study on monoclonal antibodies against CGRP and its receptor. European journal of neurology (2023)
Francesca Schiano Di Cola, Marco Bolchini, Giulia Ceccardi, Salvatore Caratozzolo, Paolo Liberini, Renata Rao, Alessandro Padovani
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor. European journal of neurology (2023)
Francesca Schiano Di Cola, Salvatore Caratozzolo, Paolo Liberini, Alessandro Padovani, Renata Rao
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination. Journal of neurology 269 (6) (2022)
Claudia Altamura, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Carlo Lovati, Valentina Favoni, Armando Perrotta, Ilaria Maestrini, Francesca Schiano Di Cola, Florindo d'Onofrio, Cinzia Finocchi, Davide Bertuzzo, Francesco Bono, Angelo Ranieri, Maria Albanese, Roberta Messina, Alberto Doretti, Vittorio DI Piero, Sabina Cevoli, Barbanti Piero, Fabrizio Vernieri, null null
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience. Journal of neurology 269 (11) (2022)
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Carlo Lovati, Davide Bertuzzo, Florindo d'Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Francesca Schiano Di Cola, Angelo Ranieri, Bruno Colombo, Francesco Bono, Maria Albanese, Sabina Cevoli, Barbanti Piero, null null
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study. European journal of neurology (2021)